Form 4 Amgen Inc For: 5 March
#Amgen Inc #Form 4 #SEC #insider trading #stock transactions #March 5 #corporate governance
📌 Key Takeaways
- Amgen Inc. filed a Form 4 with the SEC on March 5, indicating insider trading activity.
- The filing details transactions by company insiders, such as executives or directors, involving Amgen stock.
- Form 4 reports are required by the SEC to provide transparency into insider trades.
- The specific transactions, including buys, sells, or awards, are disclosed in the filing.
🏷️ Themes
SEC Filings, Insider Trading
📚 Related People & Topics
Amgen
American multinational biopharmaceutical company
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue.
Entity Intersection Graph
Connections for Amgen:
View full profileMentioned Entities
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Trump replaces Homeland Security chief Kristi Noem Oil extends weekly gains as Iran conflict rages on, with crude surging around 18% Wall Street ends lower on escalating Iran conflict, report of AI export curbs Trump says he must be involved in selecting Iran’s next leader (South Africa Philippines Nigeria) Form 4 Amgen Inc For: 5 March By Filings Published 03/05/2026, 08:24 PM Form 4 Amgen Inc For: 5 March 0 AMGN -3.06%
Read full article at source